Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F01FQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,632
Award facts
- Contract value 100% obligated
- $16,631.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $16,631.79 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, for COSENTYX (secukinumab) 300 mg/2 mL dose.
Place of performance is Conshohocken, PA. Ultimate completion date is April 7, 2026. The order is priced on a firm fixed-price basis with no set-aside. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F01FQ?
SPE2DR26F01FQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 6, 2026.
How much is contract SPE2DR26F01FQ worth?
The government has obligated $16,632 on SPE2DR26F01FQ.
Is contract SPE2DR26F01FQ an order under another contract?
Yes. SPE2DR26F01FQ is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F01FQ competed?
The extent of competition for SPE2DR26F01FQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award